Catalyst Wire Dossier Catalyst Wire Dossier

Gene replacement therapy for CTNNB1 neurodevelopmental syndrome

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gene replacement therapy for CTNNB1 neurodevelopmental syndrome, covering 2026-03-25 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: Gene Replacement Therapy for Treatment of Paediatric Patients With CTNNB1 Neurodevelopmental Syndrome [Phase 1, Phase 2]

See pricing